Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FFGP9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,889
Award facts
- Contract value 100% obligated
- $21,889.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,889.20 delivery order to AmerisourceBergen Drug Corp for 300 mg/2 mL Dupixent syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price contract represents a competitively awarded, non-set-aside procurement of the prescription biologic medication used to treat various inflammatory and allergic conditions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026.
This delivery order is issued under AmerisourceBergen's prime IDC (SPE2DX) with the Defense Logistics Agency, which functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare programs worldwide. The DLA Troop Support Medical supply chain regularly issues delivery orders for brand-name and generic pharmaceuticals to support Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of therapeutic product categories, positions the company as a primary vendor for military and veteran healthcare pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DB25FFGP9?
SPE2DB25FFGP9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FFGP9 worth?
The government has obligated $21,889 on SPE2DB25FFGP9.
Is contract SPE2DB25FFGP9 an order under another contract?
Yes. SPE2DB25FFGP9 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFGP9 competed?
The extent of competition for SPE2DB25FFGP9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award